Antibody response to respiratory syncytial virus infection in children <18 months old

Human Vaccines and Immunotherapeutics

Volumn 12, Issue 7, 2016, Pages 1700-1706

  Esposito, Susanna ^a   Scarselli, Elisa ^b   Lelii, Mara ^a   Scala, Alessia ^a   Vitelli, Alessandra ^b   Capone, Stefania ^b   Fornili, Marco ^a   Biganzoli, Elia ^a   Orenti, Annalisa ^a   Nicosia, Alfredo ^b   Cortese, Riccardo ^c   Principi, Nicola ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b ReiThera Srl ^*  (Italy)

^c Keires AG   (Switzerland)

Author keywords

neutralizing antibody; pediatric infectious diseases; respiratory tract infection; RSV; RSV vaccine

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ADOLESCENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; FEMALE; FOLLOW UP; GESTATIONAL AGE; HOSPITALIZATION; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS A; HUMAN RESPIRATORY SYNCYTIAL VIRUS B; INFANT; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; NEWBORN; NOSE SMEAR; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; UPPER RESPIRATORY TRACT INFECTION; VIRUS IDENTIFICATION; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS SHEDDING; AGE; ANTIBODY PRODUCTION; BLOOD; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOLOGY; PATHOLOGY; VIROLOGY;

AGE FACTORS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIBODY FORMATION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROSPECTIVE STUDIES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; VIRUS SHEDDING;

EID: 84963615982     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2016.1145847     Document Type: Article

References (29)

1. H.Nair, D.J.Nokes, B.D.Gessner, M.Dherani, S.A.Madhi, R.J.Singleton, K.L.O'Brien, A.Roca, P.F.Wright, N.Bruce, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010; 375:1545-55; PMID:20399493; http://dx.doi.org/10.1016/S0140-6736(10)60206-1
2. P.K.Munywoki, E.O.Ohuma, M.Ngama, E.Bauni, J.A.Scott, D.J.Nokes. Severe lower respiratory tract infection in early infancy and pneumonia hospitalizations among children, Kenya. Emerg Infect Dis 2013; 219:223-9; http://dx.doi.org/10.3201/eid1902.120940
3. M.O.Blanken, M.M.Rovers, L.Bont. Respiratory syncytial virus and recurrent wheeze. N Engl J Med 2013; 369:782-3; PMID:23964947; http://dx.doi.org/10.1056/NEJMc1307429
4. A.Eick, R.Karron, J.Shaw, B.Thumar, R.Reid, M.Santosham. The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease. Pediatr Infect Dis J 2008; 27:207-12; PMID:18277934; http://dx.doi.org/10.1097/INF.0b013e31815ac585
5. American Academy of Pediatrics Committee on Infectious Diseases; American Academy of Pediatrics Bronchiolitis Guidelines Committee. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics 2014; 134:415-20; PMID:25070315; http://dx.doi.org/10.1542/peds.2014-1665
6. J.L.Hurwitz. Respiratory syncytial virus vaccine development. Expert Rev Vaccines 2011; 10:1415-33; PMID:21988307; http://dx.doi.org/10.1586/erv.11.120
7. C.A.Shaw, M.Ciarlet, B.W.Cooper, L.Dionigi, P.Keith, K.B.O'Brien. The path to an RSV vaccine. Curr Opin Virol 2013; 3:332-42; PMID:23727193; http://dx.doi.org/10.1016/j.coviro.2013.05.003
8. B.S.Graham, K.Modjarrad, J.S.McLellan. Novel antigens for RSV vaccines. Curr Opin Immunol 2015; 35:30-8; PMID:26070108; http://dx.doi.org/10.1016/j.coi.2015.04.005
9. T.N.Kaul, R.C.Welliver, D.T.Wong, R.A.Udwadia, K.Riddlesberger, P.L.Ogra. Secretory antibody response to primary and secondary infection with respiratory syncytial virus infection. Am J Dis Child 1981; 135:1013-16; PMID:7294005
10. K.McIntosh, H.B.Masters, I.Orr, R.K.Chao, R.M.Barkin. The immunologic response to infection with respiratory syncytial virus in infants. J Infect Dis 1978; 138:24-32; PMID:355574; http://dx.doi.org/10.1093/infdis/138.1.24
11. B.R.Murphy, B.S.Graham, G.A.Prince, E.E.Walsh, R.M.Chanock, D.T.Karzon, P.F.Wright. Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. J Clin Microbiol 1986; 23:1009-14; PMID:3754878
12. L.S.Richardson, R.H.Yolken, R.B.Belshe, E.Camargo, H.W.Kim, R.M.Chanock. Enzyme-linked immunosorbent assay for measurement of serological response to respiratory syncytial virus infection. Infect Immun 1978; 20:660-64; PMID:352952
13. R.C.Welliver, T.N.Kaul, T.I.Putnam, M.Sun, K.Riddlesberger, P.L.Ogra. The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses. J Pediatr 1980; 96:808-13; PMID:7365579; http://dx.doi.org/10.1016/S0022-3476(80)80547-6
14. B.R.Murphy, D.W.Alling, M.H.Snyder, E.E.Walsh, G.A.Prince, R.M.Chanock, W.J.Rodriguez, H.W.Kim, B.S.Graham. Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection. J Clin Microbiol 1986; 24:894-98; PMID:3771779
15. A.Roca, L.Quintó, F.Abacassamo, M.P.Loscertales, F.X.Gómez-Olivé, F.Fenwick, P.A.Cane, J.C.Saiz, G.Toms, P.L.Alonso. Antibody response after RSV infection in children younger than 1 year of age living in a rural area of Mozambique. J Med Virol 2003; 69:579-87; PMID:12601767; http://dx.doi.org/10.1002/jmv.10348
16. L.K.Ball, L.A.Falk, A.D.Horne, T.M.Finn. Evaluating the immune response to combination vaccines. Clin Infect Dis 2001; 33(Suppl. 4):S299-S305; http://dx.doi.org/10.1086/322578
17. J.J.Shinoff, K.L.O'Brien, B.Thumar, J.B.Shaw, R.Reid, W.Hua, M.Santosham, R.A.Karron. Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus. J Infect Dis 2008; 198:1007-15; PMID:18702606; http://dx.doi.org/10.1086/591460
18. C.J.Sande, P.A.Cane, D.J.Nokes. The association between age and the development of respiratory syncytial virus neutralising antibody responses following natural infection in infants. Vaccine 2014; 32:4726-29; PMID:25005882; http://dx.doi.org/10.1016/j.vaccine.2014.05.038
19. K.Modjarrad, B.Giersing, D.C.Kaslow, P.G.Smith, V.S.Moorthy, WHO RSV Vaccine Consultation Expert Group. WHO consultation on respiratory syncytial virus vaccine development report from a World Health Organization meeting held on 23–24 March 2015. Vaccine 2015; 34:190-7. Epub Jun 20. pii: S0264-410X(15)00767-7; PMID:26100926; http://dx.doi.org/10.1016/j.vaccine.2015.05.093
20. P.F.Wright, W.C.Gruber, M.Peters, G.Reed, Y.Zhu, F.Robinson, S.Coleman-Dockery, B.S.Graham. Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. J Infect Dis 2002; 185:1011-18; PMID:11930309; http://dx.doi.org/10.1086/339822
21. J.P.DeVincenzo, W.T.Vaishnaw, A.Cehelsky, J.Meyers, R.Nochur, S.Harrison, L.Harrison, P.Meeking, A.Mann, E.Moane, et al. Viral load drives disease in humans experimentally infected with respiratory syncytial virus. Am J Resp Crit Care 2010; 182:1305-14; http://dx.doi.org/10.1164/rccm.201002-0221OC
22. C.M.El Saleeby, A.J.Bush, L.M.Harrison, J.A.Aitken, J.P.Devincenzo. Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children. J Infect Dis 2011; 204:996-1002; PMID:21881113; http://dx.doi.org/10.1093/infdis/jir494
23. L.Zhou, Q.Xiao, Y.Zhao, A.Huang, L.Ren, E.Liu. The impact of viral dynamics on the clinical severity of infants with respiratory syncytial virus bronchiolitis. J Med Virol 2015; 87:1276-84; PMID:25907780; http://dx.doi.org/10.1002/jmv.24111
24. F.M.Munoz. Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy? Curr Opin Infect Dis 2015; 28:221-24; PMID:25918956; http://dx.doi.org/10.1097/QCO.0000000000000161
25. R.D.Feigin, J.D.Cherry (eds). Textbook of pediatric infectious diseases; 6th ed, 2009. W.B. Saunders Company. Philadelphia.
26. S.Gove. Integrated management of childhood illness by outpatient health workers: technical basis and overview: the WHO Working Group on Guidelines for Integrated Management of the Sick Child. Bull World Health Organ 1997; 75 (Suppl. 1):7-24; PMID:9529714
27. L.J.van Elden, A.M.van Loon, A.van der Beek, K.A.Hendriksen, A.I.Hoepelman, M.G.van Kraaij, P.Schipper, M.Nijhuis. Applicability of a real-time quantitative PCR assay for diagnosis of respiratory syncytial virus infection in immunocompromised adults. J Clin Microbiol 2003; 41:4378-81; PMID:12958272; http://dx.doi.org/10.1128/JCM.41.9.4378-4381.2003
28. S.Esposito, A.Piralla, A.Zampiero, S.Bianchini, G.Di Pietro, A.Scala, R.Pinzani, E.Fossali, F.Baldanti, N.Principi. Characteristics and their clinical relevance of respiratory syncytial virus types and genotypes circulating in Northern Italy in five consecutive winter seasons. PLoS One 2015; 10:e0129369; PMID:26047100; http://dx.doi.org/10.1371/journal.pone.0129369
29. R Core Team 2015. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org/), version 3.1.1.